Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Avita Medical Inc (RCEL)

71 + Investors. Track Smart Money conviction in RCEL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -4
Streak
1Q ▼
Buyers last Q
48%

Smart Money Signals — RCEL

Based on 73 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their RCEL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 90% of 3.0Y peak

90% of all-time peak
73 funds currently hold this stock — 90% of the 3.0-year high of 81 funds (reached 2023 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 8% fewer funds vs a year ago

fund count last 6Q
6 fewer hedge funds hold RCEL compared to a year ago (-8% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 48% buying

46 buying49 selling
Last quarter: 49 funds reduced or exited vs 46 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~23 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 17 → 8 → 26 → 23. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

44% of holders stayed for 2+ years

■ 44% conviction (2yr+) ■ 21% medium ■ 36% new
32 out of 73 hedge funds have held RCEL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

16 → 17 → 8 → 26 → 23 new funds/Q
New funds entering each quarter: 17 → 8 → 26 → 23. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 49% veterans vs 37% newcomers

■ 49% veterans ■ 13% 1-2yr ■ 37% new
Entry-cohort mix of 75 holders: 37 (49%) are 2+ year veterans, 10 entered 1–2 years ago, and 28 (37%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 43% AUM from top-100 funds

43% from top-100 AUM funds
24 of 72 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in RCEL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RCEL

In 2026 Q2, 46 hedge funds were net buyers of RCEL (23 opened a new position, 23 added to an existing one), while 49 reduced or exited (22 trimmed, 27 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. 43% of total institutional value in RCEL is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -4 funds (more exits than new entries). Total institutional holders: 73.

Hedge Fund Ownership: RCEL

How many hedge funds hold RCEL — quarterly history vs. share price
Quarterly hedge fund ownership of RCEL vs. share price

Market Analysis: RCEL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RCEL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Avita Medical Inc (RCEL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much RCEL has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 87d ago
RCEL
+165.1%
XLV
+8.2%

RCEL outperformed XLV by +156.9% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 42d ago
RCEL
+39.5%
XLV
+2.6%

Since the filing became public, RCEL outperformed XLV by +36.9% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 0 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: RCEL
71 + Investors

Track Smart Money conviction in RCEL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 71 77 -7.79%
13F Shares 5M 87M -94.3%
Total Value $20M $226M -90.94%
New Positions 22 26 -4
Increased Positions 24 26 -2
Closed Positions 27 16 +11
Reduced Positions 20 11 +9
Total Calls 1 2 -50.0%
Total Puts 2 0 100%
PUT/CALL Ratio 2.0 0.0 Bearish

Statistics: RCEL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

71 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RCEL. Verified SEC 13F-HR filings.

QUARTER:
Top 25 RCEL holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 nVerses Capital, LLC 0.09% 13,668 $56K
2 Thompson Davis & CO., INC. 0.08% 31,090 $128K
3 R Squared Ltd 0.05% 22,883 $95K
4 Abel Hall, LLC 0.01% 15,779 $65K
5 Divisadero Street Capital Management, LP 0.01% 100,000 $413K
6 China Universal Asset Management Co., Ltd. 0.00% 12,500 $52K
7 XTX Topco Ltd 0.00% 57,161 $236K
8 Macquarie Group Ltd 0.00% 144,164 $595K
9 IHT Wealth Management, LLC 0.00% 24,600 $102K
10 NewEdge Advisors, LLC 0.00% 148,931 $615K
11 Marshall Wace, LLP 0.00% 338,387 $1.4M
12 Essential Partners LLC 0.00% 433 $2K
13 Ieq Capital, LLC 0.00% 32,400 $134K
14 Quantinno Capital Management LP 0.00% 105,248 $435K
15 Jain Global LLC 0.00% 30,775 $127K
16 Aqr Capital Management LLC 0.00% 321,013 $1.3M
17 Quadrature Capital Ltd 0.00% 11,829 $49K
18 Gabelli Funds LLC 0.00% 15,000 $62K
19 Qube Research & Technologies Ltd 0.00% 63,784 $263K
20 Tower Research Capital LLC (TRC) 0.00% 2,273 $9K
21 Arax Advisory Partners 0.00% 7,153 $30K
22 Vanguard Fiduciary Trust Co 0.00% 182,402 $753K
23 True Wealth Design, LLC 0.00% 147 —
24 Vanguard Capital Management LLC 0.00% 1,333,914 $5.5M
25 Arrowstreet Capital, Limited Partnership 0.00% 60,746 $251K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Avita Medical Inc (RCEL)

What does the Smart Money Trend signal show for RCEL?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their RCEL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for RCEL?

More sellers than buyers — 48% buying: Last quarter: 49 funds reduced or exited vs 46 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for RCEL holders?

Elite ownership — 43% AUM from top-100 funds: 24 of 72 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in RCEL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held RCEL?

44% of holders stayed for 2+ years: 32 out of 73 hedge funds have held RCEL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Avita Medical Inc (RCEL) following the 2026 Q2 hedge fund 13F filings?

As of today, RCEL has moved +39.5% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.6% for the XLV sector ETF — an outperformance of +36.9%. Since the quarter end (June 30, 2026), RCEL has gained +165.1% vs +8.2% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →